White Paper
Digital Twins in the pharmaceutical industry Progress report
This white paper details how Digital Twins in pharma enhance patient safety and combat counterfeiting by tracking each product’s life cycle via serialization. Regulations like the EU FMD, US DSCSA, and Russia’s aggregation codes demand secure, long-term data management and cross-border communication. Implemented through cloud-based SaaS, Digital Twins link manufacturers, logistics, and authorities. Lessons include avoiding over-standardization, ensuring continuous validation, aligning tools with requirements, and clearly defining IT system roles. The pharma model showcases how regulatory-driven digitization can rapidly modernize complex industries.
